QualiPain: Qualitative Study for Pain Measurement Using Innovative Health Technology

Sponsor
University Hospital Schleswig-Holstein (Other)
Overall Status
Completed
CT.gov ID
NCT03727373
Collaborator
European Regional Development Fund (Other), Zealand University Hospital (Other), Design School Kolding (Other)
8
2
1.2
4
3.3

Study Details

Study Description

Brief Summary

The present study is a multicenter, explorative, qualitative study. The primary endpoint of this study is to evaluate to which extent the collection of data with regard to pain caused by illness or treatment can be optimized using health technology solutions. For this evaluation semi-structured qualitative interviews with 8-10 patients will be conducted.

Secondary variables are the evaluation of the patients' pain experience and the general patients' willingness to collect data with regard to pain by using technological devices themselves or with support of healthcare professionals.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The present multicenter study is an explorative, qualitative study. It shall be evaluated from the patients' point of view if and how the collection of data with regard to pain, caused by illness or treatment, can be optimized using health technology solutions. A health technology solution could for example be an app for registering the intensity and localization of pain. The aim of this study is to examine, if such a solution would be accepted by patients with acute or chronic pain and how a fitting solution should be designed to meet the patients' requirements. Existing methods for pain measurement as well as possibilities for the development of new methods will be examined and evaluated during the interviews.

    To arguable this issue the interviews comprise different topics like:
    • the patients pain experience in everyday life, e.g. how the patients cope with pain in everyday life and how and if this is documented;

    • experiences with and the thought of regular pain recording;

    • an evaluation if patients tend to be willing to record their pain using technological devices by themselves or rather with support of healthcare professionals.

    It is the aim to use the results of this study for the development of a new and improved version of pain registration. The results of the study will be summarized in a report and handed over to a startup company. Thereupon the startup company has the possibility to develop a technological solution that represents the patients' need at its best.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    8 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Qualitative Study for Pain Measurement Using Innovative Health Technology (QualiPain)
    Actual Study Start Date :
    Oct 17, 2018
    Actual Primary Completion Date :
    Nov 23, 2018
    Actual Study Completion Date :
    Nov 23, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Number of Participants Willing to Assess Their Pain Using Technology [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain using technology.

    Secondary Outcome Measures

    1. Number of Participants Impaired by Pain During Daily Life [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were impaired by pain during their daily life.

    2. Number of Participants Satisfied With Assessment of Pain Performed by Medical Staff Members [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were satisfied with the assessment of their pain when performed by medical staff members.

    3. Number of Participants Considering Regular Assessment of Pain Important [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were considering regular assessment of their pain important.

    4. Number of Participants Already Using Technology for Assessment of Pain or Other Medical Symptoms/Outcomes (e.g. Blood Pressure) [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were already using technology for assessment of pain or other medical symptoms/outcomes (e.g. blood pressure).

    5. Number of Participants Willing to Assess Their Pain Themselves [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain themselves.

    6. Number of Participants Willing to Assess Their Pain Using Technology, if Required by Treating Physician [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain using technology, if required by their treating physician.

    7. Number of Participants Willing to Assess Their Pain Using Technology for Their Own Interest Only [1 day (during the interview)]

      Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain using technology, if this was for their own interest only.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years or older

    • Pain intensity > 4 (numeric ranking scale 0-10)

    • Legal capacity

    • Written informed consent

    Exclusion Criteria:
    • Lack of willingness to cooperate

    • Lack of consent

    • Lack of ability to follow instructions

    • younger than 18 years

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Neurosurgery, University Medical Center Schleswig-Holstein Campus Lübeck Lübeck Schleswig-Holstein Germany 23538
    2 Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein Lubeck Germany 23562

    Sponsors and Collaborators

    • University Hospital Schleswig-Holstein
    • European Regional Development Fund
    • Zealand University Hospital
    • Design School Kolding

    Investigators

    • Principal Investigator: Dirk Rades, Prof. Dr., Dep. of Radiation Oncology, Univ. Medical Center S-H Campus Lübeck (Germany)

    Study Documents (Full-Text)

    More Information

    Publications

    Responsible Party:
    Prof. Dirk Rades, MD, Professor Dr. med., University Hospital Schleswig-Holstein
    ClinicalTrials.gov Identifier:
    NCT03727373
    Other Study ID Numbers:
    • QualiPain
    First Posted:
    Nov 1, 2018
    Last Update Posted:
    Mar 27, 2020
    Last Verified:
    Mar 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Prof. Dirk Rades, MD, Professor Dr. med., University Hospital Schleswig-Holstein
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Period Title: Overall Study
    STARTED 8
    COMPLETED 8
    NOT COMPLETED 0

    Baseline Characteristics

    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Overall Participants 8
    Age, Customized (years) [Median (Full Range) ]
    Age
    62
    Sex: Female, Male (Count of Participants)
    Female
    3
    37.5%
    Male
    5
    62.5%
    Race/Ethnicity, Customized (Count of Participants)
    Caucasian
    8
    100%
    Region of Enrollment (participants) [Number]
    Germany
    8
    100%
    Type of pain (Count of Participants)
    Acute pain
    4
    50%
    Chronic pain
    4
    50%

    Outcome Measures

    1. Primary Outcome
    Title Number of Participants Willing to Assess Their Pain Using Technology
    Description Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain using technology.
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Willing to assess pain using technology
    5
    62.5%
    Not willing to assess pain using technology
    3
    37.5%
    2. Secondary Outcome
    Title Number of Participants Impaired by Pain During Daily Life
    Description Patients were asked during a semi-structured qualitative interview, if they were impaired by pain during their daily life.
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Impaired by pain during daily life
    7
    87.5%
    Not impaired by pain during daily life
    1
    12.5%
    3. Secondary Outcome
    Title Number of Participants Satisfied With Assessment of Pain Performed by Medical Staff Members
    Description Patients were asked during a semi-structured qualitative interview, if they were satisfied with the assessment of their pain when performed by medical staff members.
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Satisfied with pain-assessment by medical staff
    5
    62.5%
    Not satisfied with pain-assessment by med. staff
    3
    37.5%
    4. Secondary Outcome
    Title Number of Participants Considering Regular Assessment of Pain Important
    Description Patients were asked during a semi-structured qualitative interview, if they were considering regular assessment of their pain important.
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Considering regular pain-assessment important
    4
    50%
    Not considering regular pain-assessment important
    4
    50%
    5. Secondary Outcome
    Title Number of Participants Already Using Technology for Assessment of Pain or Other Medical Symptoms/Outcomes (e.g. Blood Pressure)
    Description Patients were asked during a semi-structured qualitative interview, if they were already using technology for assessment of pain or other medical symptoms/outcomes (e.g. blood pressure).
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Already using technology
    7
    87.5%
    Not already using technology
    1
    12.5%
    6. Secondary Outcome
    Title Number of Participants Willing to Assess Their Pain Themselves
    Description Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain themselves.
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Willing to assess pain themselves
    4
    50%
    Not willing to assess pain themselves
    4
    50%
    7. Secondary Outcome
    Title Number of Participants Willing to Assess Their Pain Using Technology, if Required by Treating Physician
    Description Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain using technology, if required by their treating physician.
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Willing to use technology (required by physician)
    5
    62.5%
    Not willing to use technology (requ. by physician)
    3
    37.5%
    8. Secondary Outcome
    Title Number of Participants Willing to Assess Their Pain Using Technology for Their Own Interest Only
    Description Patients were asked during a semi-structured qualitative interview, if they were willing to assess their pain using technology, if this was for their own interest only.
    Time Frame 1 day (during the interview)

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    Measure Participants 8
    Willing to use technology (own interest only)
    2
    25%
    Not willing to use technology (own interest only)
    6
    75%

    Adverse Events

    Time Frame 1 day (day of the interview)
    Adverse Event Reporting Description
    Arm/Group Title Patients With Acute or Chronic Pain
    Arm/Group Description Patients included in this study must have had acute or chronic pain with an intensity of >4 on a numeric self-rating scale ranging from 0 to 10 (0=no pain, 10=maximum pain).
    All Cause Mortality
    Patients With Acute or Chronic Pain
    Affected / at Risk (%) # Events
    Total 0/8 (0%)
    Serious Adverse Events
    Patients With Acute or Chronic Pain
    Affected / at Risk (%) # Events
    Total 0/8 (0%)
    Other (Not Including Serious) Adverse Events
    Patients With Acute or Chronic Pain
    Affected / at Risk (%) # Events
    Total 0/8 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Prof. Dr. med. Dirk Rades
    Organization Department of Radiation Oncology, University of Lübeck, Germany
    Phone 0049 451 500 ext 45401
    Email dirk.rades@uksh.de
    Responsible Party:
    Prof. Dirk Rades, MD, Professor Dr. med., University Hospital Schleswig-Holstein
    ClinicalTrials.gov Identifier:
    NCT03727373
    Other Study ID Numbers:
    • QualiPain
    First Posted:
    Nov 1, 2018
    Last Update Posted:
    Mar 27, 2020
    Last Verified:
    Mar 1, 2020